Health

Sunscreens could cause Vitamin D deficiency: Study

Sunscreens cause Vitamin D deficiency: Study

Sunscreens have proved their worth in providing protection against skin cancer, but a new study has warned that they might make the user deficient in Vitamin D.

Kim Pfotenhauer, an assistant professor at California’s Touro University, pointed out that applying sunscreens essentially nullifies the body’s ability to absorb vitamin D from sunlight.

Speaking on the topic, Pfotenhauer said, “People are spending less time outside and when they do go out they're typically wearing sunscreen, which essentially nullifies the body’s ability to produce vitamin D.”

Gluten-free diets don’t slash risk of heart disease: Research

Gluten-free diets don’t slash risk of heart disease

While some health experts have been recommending gluten-free diets, a new study has suggested that avoiding gluten doesn’t lower the risk of heart disease. After making adjustments for risk factors, researchers found that those in the highest 5th of estimated gluten intake showed a multiple-variable hazard ratio of 0.95 (95 per cent CI 0.88 to 1.02; P=0.29) for coronary heart disease. Additional adjustment for whole grains showed a multivariate hazard ratio of 1.00 (95 per cent CI 0.92 to 1.09; P=0.77) for the same condition.

Tick-borne Powassan virus on the rise: experts warn

Tick-borne Powassan virus on the rise: experts warn

Newborn babies, the elderly and people with weak immune system are at a higher risk of contracting a rare tick-borne disease called Powassan, health experts have warned.

The potentially life-threatening virus in question is carried and transmitted by multiple kinds of ticks, including the deer tick which is also responsible for transmitting Lyme disease.

Medical Marijuana Companies Sue New York Regarding Issuing of New Licenses

Medical Marijuana Companies Sue New York Regarding Issuing of New Licenses

Four medical marijuana companies have sued New York regarding the issue of new licenses. As the state wanted to grant licenses to five more companies for selling marijuana products in New York, four already licensed companies have joined hands to protest against the decision. The collective lawsuit has been filed by Vireo Health of New York, PharmaCannis, Etain and Bloomfield Industries and Columbia Care. As per initial media reports, the lawsuit has been filed by the New York Medical Cannabis Industry Association in state Supreme Court in Albany.

Low dose of Aspirin Could Lower Breast Cancer Risk: Research

Low dose of Aspirin Could Lower Breast Cancer Risk: Research

Low intensity dosage of aspirin (81 mg) on a regular basis can lower the risk of the most common type of breast cancer among women, according to a City of Hope-led study. The study is the first to find a link between low dose of aspirin and breast cancer risk. Detailed study results have been published in journal Breast Cancer Research. The study was proposed by City of Hope's Leslie Bernstein, Ph.D., professor and director of the Division of Biomarkers of Early Detection and Prevention. Dr.

Supply of Yellow Fever vaccine is dwindling: CDC

Supply of Yellow Fever vaccine is dwindling: CDC

The supply of yellow fever vaccine is dwindling in the United States and it will likely run out by the end of this summer, federal health authorities warned on Friday.

The Centers for Disease Control & Prevention (CDC) also made it clear that it has no way to produce more of the vaccine due to a manufacturing issue.

The shortage of the yellow fever vaccine comes at a really troubling time as the nation has witnessed multiple outbreaks of the disease, which is transmitted by infected mosquitoes.

Tags: 

Brineura Wins FDA Approval for Type of Batten Disease

Brineura Wins FDA Approval for Type of Batten Disease

The U.S. FDA has approved Brineura for treatment of a rare type of Batten Disease. One type of neuronal ceroid lipofuscinoses (collectively termed as Batten Disease), primarily affects the nervous system at an early age. The symptoms include language delays, ataxia and epilepsy. The symptoms usually show up between age 2 and 4 years and in certain cases, the disease even leads to vision loss.

Tags: 

Study explores link between high diet soda consumption and dementia risk

Study explores link between high diet soda consumption and dementia risk

Diet soda and artificial sweeteners have been under scrutiny and many research projects have tried to check the impact of long term consumption of artificial sweeteners on health. A new study has tried to find a link between high consumption of artificial sweeteners and diabetes, dementia and stroke risk. The new study published in the American Heart Association’s journal Stroke has found that risk of developing dementia and suffering from stroke was three times higher for people who consumed at least one beverage with artificial sweetener per day.

‘Bad Luck’ Mutations Linked to Higher Cancer Risk in New Study

‘Bad Luck’ Mutations Linked to Higher Cancer Risk in New Study

Nearly 66 percent of the genetic mutations that turn into cancer are caused by ‘random replication errors’ during ongoing cell replacement process and environmental factors account for 29 percent of mutations that lead to cancer, as per a new study. The study published in the journal Science has estimated that 5 percent of mutations are inherited and environment plays a smaller role compared to what was estimated by medical researchers earlier.

Amgen’s Repatha Reduces Cholesterol and Cuts Risk of Cardiovascular-related Deaths: Report

Amgen’s Repatha Reduces Cholesterol and Cuts Risk of Cardiovascular-related Deaths: Report

Amgen’s Repatha has showcased impressive results in reduction of LDL cholesterol and death due to cardiovascular-related reasons. In a clinical trial, Repatha, a man-made antibody also known as evolocumab, has been associated with 20 percent reduction in risk of death due to heart attack, stroke and cardiovascular-related issues. However, the high cost of treatment has already started a debate on the drug and ever increasing drug prices. Repatha would cost nearly $14,000 per year and this cost is considerably higher compared to other options available for reducing LDL cholesterol.

Pages

Subscribe to RSS - Health